Developing affordable tests for detecting hepatitis C and HIV from blood samples

Integrating low-cost and versatile technologies to achieve colorimetric HCV and HIV detection from whole blood

['FUNDING_R01'] · EMORY UNIVERSITY · NIH-10779734

This study is working on a quick and easy test that can check for hepatitis C and HIV from a single blood sample, making it simpler for healthcare workers to help patients get the care they need right away.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorEMORY UNIVERSITY (nih funded)
Locations1 site (ATLANTA, UNITED STATES)
Trial IDNIH-10779734 on ClinicalTrials.gov

What this research studies

This research aims to create a simple and cost-effective test that can detect hepatitis C virus (HCV) and HIV from whole blood samples in a single visit. By utilizing innovative technologies and methods, the project seeks to eliminate the need for complicated two-stage testing, which currently delays diagnosis and treatment. The goal is to enable healthcare workers, even those with minimal training, to perform these tests quickly and accurately, improving patient access to necessary care.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who are at risk for or currently infected with hepatitis C or HIV.

Not a fit: Patients who have already been diagnosed and are receiving treatment for hepatitis C or HIV may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could significantly enhance the speed and accessibility of HCV and HIV diagnostics, leading to earlier treatment and better health outcomes for patients.

How similar studies have performed: Previous research has shown promise in developing rapid diagnostic tests for viral infections, indicating that this approach could lead to successful outcomes.

Where this research is happening

ATLANTA, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.